Cytek Biosciences Inc (CTKB) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cytek Biosciences Inc   (NASDAQ: CTKB)


Cytek Biosciences Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cytek Biosciences Inc's ROI in the second quarter of 2026?
Cytek Biosciences Inc recorded a cumulative net loss of $-58 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -15.23%.

Within the Healthcare sector 223 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3167 to 3195.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -8.78 % -5.86 % -3.82 % -1.69 % -3.33 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 354 368 384 420 413
Return On Investment (TTM) -15.23 % -15.94 % -17.92 % -3.07 % -1.53 %
CTKB's Overall Ranking # 3195 # 3167 # 2370 # 2510 #
Seq. Investment Change TTM -3.7 % -2.86 % -2.43 % -0.06 % -0.61 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -58 -63 -73 -13 -6

CTKB Company Profile >> Back to CTKB Roi Comparisons >> See Annual CTKB Return On Investment



Return On Investment CTKB's Ranking
Within: No.
Industry # 11
Sector # 224
Overall # 3195

Return On Investment Statistics
High Average Low
5.28 %
-3.34 %
-17.46 %
(Jun 30 2021)   (Dec 31 2025)



  News about Cytek Biosciences Inc Return on Investment ROI

Cytek Biosciences: Pioneering Cell Analysis Solutions, Outperforming Expectations

January 8, 2024



In exciting news for the biotechnology industry, Cytek Biosciences, a renowned player in cell analysis solutions, has recently unveiled their preliminary full-year revenue results. With a commitment to innovation and cutting-edge technology, Cytek Biosciences has impressed investors and analysts alike, showcasing robust growth in an ever-evolving market. This article delves into Cytek Biosciences recent achievements, highlights their strategic approach, and explores the factors behind their impressive revenue surge.
The Initial Announcement:
On January 8, 2024, Cytek Biosciences issued an eagerly anticipated press release stating the unaudited revenue results for the full year ended December 31, 2023. As a publicly-traded company on Nasdaq (CTKB), the announcement carried significant weight, catching the attention of Wall Street investors, industry experts, and biotech enthusiasts alike. The preliminary figures provided a glimpse into Cytek Biosciences remarkable growth trajectory.





Financial Statements
Cytek Biosciences Inc's II. Quarter Investments $ 354 Millions CTKB's Balance sheet
Cytek Biosciences Inc's II. Quarter Income $ -1 Millions Quarterly CTKB's Income Statement
CTKB's Income by Division See CTKB's Income by Division


CTKB Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 370 424 429 458 430
Y / Y Investment Growth -12.87 % -1.04 % -6.41 % 6.51 % -
Net Income in Millions -67 -6 -12 3 3
Y / Y Net Income Growth - - - -12.61 % -
Annual Return On Investment -18 % -1.42 % -2.83 % 0.58 % 0.71 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CTKB's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CTKB's Competitors
Subscribers only: Roi for Cytek Biosciences Inc's Suppliers
Subscribers only: Return On Investment for CTKB's Customers

Other Ratios
CTKB's Roa CTKB's Inventory Turnover Ratio CTKB's Growth Rates CTKB's Dividend Statistics
CTKB's Profitability Ratios CTKB's Asset Turnover Ratio CTKB's Dividend Growth
CTKB's Roe CTKB's Valuation Ratios CTKB's Financial Strength Ratios CTKB's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-09T02:02:00+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.